Division of Basic Medical Research Research Program on HIV/AIDS

Life-long treatment is required to control HIV infection, because it is incurable; therefore, the selection of drug-resistant viruses is still a major issue. Controlling comorbidities associated with HIV infection is also challenging. To overcome these issues, this program aims to employ the following strategies:

1. Development of new vaccines and antiretrovirals (ARVs) for HIV infection;
2. Elucidating the infection mechanisms of HIV resulting in new treatment strategies;
3. Elucidating HIV-associated pathogenesis and development of treatments for the conditions.

PS (Program Supervisor)

• BABA Masanori, Specially Appointed Professor, Center for Advanced Science Research and Promotion Kagoshima University

PO (Program Officer)

• TACHIKAWA Natsuo, Director, Nayoro City General Hospital Department of General Medicine
• FUJITA Mikako, Specially Appointed Professor, Kumamoto University
• MIURA Toshiyuki, Director, AstraZeneca
• YOSHIMURA Kazuhisa, Director General, Tokyo Metropolitan Government, Institute of Public Health Bureau of Social Welfare and Public Health